Replimune Historical Financial Ratios
| REPL Stock | USD 12.84 0.20 1.58% |
Replimune is promptly reporting on over 97 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 4.37, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 0.0 will help investors to properly organize and evaluate Replimune Group financial condition quickly.
Replimune |
About Replimune Financial Ratios Analysis
Replimune GroupFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Replimune investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Replimune financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Replimune history.
Replimune Financial Ratios Chart
Add Fundamental
Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Income Quality
An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.Most ratios from Replimune's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Replimune Group current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Replimune Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. At this time, Replimune's Interest Debt Per Share is quite stable compared to the past year. Debt To Assets is expected to rise to 0.10 this year, although the value of Free Cash Flow Yield is projected to rise to (0.35).
Replimune fundamentals Correlations
Click cells to compare fundamentals
Replimune Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Replimune fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 1.86 | 2.83 | 2.16 | 1.85 | 1.37 | 1.44 | |
| Book Value Per Share | 5.36 | 10.78 | 7.88 | 9.54 | 5.63 | 4.37 | |
| Free Cash Flow Yield | (0.2) | (0.0452) | (0.0953) | (0.13) | (0.37) | (0.35) | |
| Operating Cash Flow Per Share | (1.77) | (1.33) | (1.57) | (2.2) | (2.79) | (2.93) | |
| Capex To Depreciation | 12.27 | 1.4 | 1.09 | 0.93 | 2.13 | 2.03 | |
| Pb Ratio | 1.86 | 2.83 | 2.16 | 1.85 | 1.37 | 1.44 | |
| Free Cash Flow Per Share | (1.96) | (1.38) | (1.62) | (2.24) | (2.87) | (3.01) | |
| Roic | (0.23) | (0.3) | (0.16) | (0.29) | (0.56) | (0.53) | |
| Net Income Per Share | (1.54) | (1.75) | (2.26) | (2.99) | (3.24) | (3.4) | |
| Payables Turnover | 0.53 | 1.76 | 1.23 | 0.46 | 1.03 | 0.54 | |
| Cash Per Share | 4.92 | 10.3 | 7.58 | 10.02 | 6.32 | 4.79 | |
| Pocfratio | (5.64) | (22.99) | (10.79) | (8.03) | (2.77) | (2.91) | |
| Capex To Operating Cash Flow | (0.11) | (0.039) | (0.0284) | (0.0177) | (0.0305) | (0.0321) | |
| Pfcf Ratio | (5.09) | (22.12) | (10.49) | (7.89) | (2.69) | (2.83) | |
| Days Payables Outstanding | 693.64 | 207.68 | 297.74 | 800.11 | 354.41 | 336.69 | |
| Income Quality | 0.82 | 1.15 | 0.76 | 0.7 | 0.73 | 0.86 | |
| Roe | (0.22) | (0.29) | (0.16) | (0.31) | (0.58) | (0.55) | |
| Ev To Operating Cash Flow | (5.35) | (20.55) | (9.9) | (7.36) | (2.78) | (2.92) | |
| Pe Ratio | (6.49) | (17.45) | (7.51) | (5.9) | (2.38) | (2.5) | |
| Return On Tangible Assets | (0.22) | (0.15) | (0.26) | (0.27) | (0.44) | (0.46) | |
| Ev To Free Cash Flow | (4.83) | (19.78) | (9.62) | (7.23) | (2.7) | (2.83) | |
| Earnings Yield | (0.15) | (0.0573) | (0.13) | (0.17) | (0.42) | (0.4) | |
| Net Debt To E B I T D A | 0.34 | 1.95 | 0.64 | 0.5 | (0.006134) | (0.005827) | |
| Current Ratio | 14.68 | 33.25 | 19.46 | 17.52 | 10.72 | 13.37 | |
| Tangible Book Value Per Share | 5.36 | 10.78 | 7.88 | 9.54 | 5.63 | 4.37 | |
| Graham Number | 13.61 | 20.6 | 20.02 | 25.35 | 20.26 | 11.89 | |
| Shareholders Equity Per Share | 5.36 | 10.78 | 7.88 | 9.54 | 5.63 | 4.37 | |
| Capex Per Share | 0.19 | 0.0517 | 0.0447 | 0.039 | 0.0851 | 0.0539 | |
| Graham Net Net | 3.51 | 9.39 | 6.66 | 8.49 | 4.67 | 3.63 | |
| Enterprise Value Over E B I T D A | (6.16) | (16.5) | (7.11) | (5.53) | (2.24) | (2.35) | |
| Price Earnings Ratio | (6.49) | (17.45) | (7.51) | (5.9) | (2.38) | (2.5) | |
| Price Book Value Ratio | 1.86 | 2.83 | 2.16 | 1.85 | 1.37 | 1.44 | |
| Price Earnings To Growth Ratio | (0.41) | (1.28) | (0.26) | (0.18) | (0.29) | (0.3) | |
| Days Of Payables Outstanding | 693.64 | 207.68 | 297.74 | 800.11 | 354.41 | 336.69 | |
| Price To Operating Cash Flows Ratio | (5.64) | (22.99) | (10.79) | (8.03) | (2.77) | (2.91) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Replimune Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.04) | Return On Assets (0.27) | Return On Equity (0.50) |
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.